Natera, Inc.
Provides non-invasive cfDNA tests for oncology, women's health, and organ health.
NTRA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6323071042
- LEI:
- Country:
- United States of America
- Address:
- 13011 MCCALLEN PASS, 78753 AUSTIN
- Website:
- https://www.natera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Natera, Inc. is a global leader in cell-free DNA (cfDNA) testing and molecular diagnostics. The company develops and commercializes non-invasive tests focused on oncology, women's health, and organ health. Utilizing proprietary technology, Natera's tests analyze cfDNA from a simple blood draw to identify genetic risks, detect cancer recurrence, and monitor organ transplant health. Its key products, such as the Signatera™ molecular residual disease test, are designed to provide early, actionable insights that enable physicians and patients to make more informed and personalized healthcare decisions. The company's tests are supported by extensive clinical validation, including numerous peer-reviewed publications and large-scale studies, and are processed in its CAP/CLIA-certified laboratories.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Natera, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Natera, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Natera, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
